Today's Veterinary Practice

SEP-OCT 2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/1015043

Contents of this Issue

Navigation

Page 20 of 79

For more information, visit Credelio.com or speak with your Elanco representative today * Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick) and Rhipicephalus sanguineus (brown dog tick). **8 weeks of age and older and 4.4 pounds and greater. My world just isn't the same when I have ticks* and fleas. Prescribe me Credelio ® (lotilaner)—a small, tasty 1 chewable that acts fast 2,3 to protect puppies and dogs** like me all month long. USCACCRD00020(3) Credelio, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2018 Elanco or its affiliates. 1. Karadzovska, D., et al. (2017). A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA. Parasites & Vectors, 10:528. 2. Murphy, M., et al. (2017). Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs. Parasites & Vectors,10:541. 3. Cavalleri, D., et al. (2017). Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs. Parasites & Vectors, 10:529. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures. The most frequently reported adverse reactions are weight loss, elev ated blood urea nitrogen, excessive urination, and diarrhea. For product information, including complete safety information, see page XX. 22

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - SEP-OCT 2018